Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ROSIGLITAZONE MALEATE

ROSIGLITAZONE MALEATE

Standard Dose
EQ 4MG BASE
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ROSIGLITAZONE MALEATE is listed in Drugs@FDA under application 076747 (ANDA).

Marketing status: Discontinued Active ingredient ROSIGLITAZONE MALEATE Form and strength TABLET;ORAL - EQ 4MG BASE Sponsor ANI PHARMS Submission history Latest submission status date: 2014-05-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview ROSIGLITAZONE MALEATE is listed in Drugs@FDA under application 076747 (ANDA). Marketing status: Discontinued Active ingredient ROSIGLITAZONE MALEATE Form and strength TABLET;ORAL - EQ 4MG BASE Sponsor ANI PHARMS Submission history Latest submission status date: 2014-05-07 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.